Among the various types of tumors screened, we focused on exploring the role of KIAA1114 in human liver cancer, including HCC and cholangiocarcinoma (CC), based on our observation of the potential correlation between KIAA1114 expression levels and tumor progression. Here, TRO is linked to cholangiocarcinoma.